(CNO) CNO Financial - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US12621E1038
CNO EPS (Earnings per Share)
CNO Revenue
CNO: Health Insurance, Life Insurance, Annuities, Long-Term Care
CNO Financial Group Inc (NYSE:CNO) is a leading provider of insurance and financial services products tailored to the needs of middle-income Americans, particularly those in pre-retirement and retirement. Through its subsidiaries, the company offers a diverse range of products, including Medicare supplement, long-term care insurance, life insurance, and annuities, which are sold through various channels, including phone, online, and in-person sales.
The companys product portfolio is designed to address the specific needs of its target market, with a focus on providing supplemental health and life insurance products to individuals and businesses. CNO Financial Groups products are marketed under well-established brand names, including Bankers Life, Washington National, and Colonial Penn, which have a strong presence in the US insurance market.
From a business perspective, CNO Financial Group has a strong track record of serving the middle-income market, with a particular emphasis on retirees and pre-retirees. The companys products are designed to provide financial security and stability, and its distribution channels are geared towards providing a personalized sales experience. With a market capitalization of $3.68 billion, CNO Financial Group is a significant player in the US life and health insurance industry.
Analyzing the
Our forecast is based on a combination of technical and fundamental analysis, taking into account the companys strong brand presence, diversified product portfolio, and relatively undervalued stock price. However, its essential to note that the insurance industry is subject to various regulatory and market risks, which may impact CNO Financial Groups future performance. As such, investors should carefully consider these factors before making any investment decisions.
Additional Sources for CNO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CNO Stock Overview
Market Cap in USD | 3,758m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 1987-01-01 |
CNO Stock Ratings
Growth Rating | 81.6 |
Fundamental | 16.8 |
Dividend Rating | 64.4 |
Rel. Strength | 11.3 |
Analysts | 2.83 of 5 |
Fair Price Momentum | 37.48 USD |
Fair Price DCF | 96.69 USD |
CNO Dividends
Dividend Yield 12m | 1.76% |
Yield on Cost 5y | 4.89% |
Annual Growth 5y | 6.03% |
Payout Consistency | 100.0% |
Payout Ratio | 15.3% |
CNO Growth Ratios
Growth Correlation 3m | -48.4% |
Growth Correlation 12m | 76.4% |
Growth Correlation 5y | 79.2% |
CAGR 5y | 22.60% |
CAGR/Max DD 5y | 0.59 |
Sharpe Ratio 12m | 0.75 |
Alpha | 29.45 |
Beta | 0.854 |
Volatility | 26.56% |
Current Volume | 622.2k |
Average Volume 20d | 608.2k |
As of June 16, 2025, the stock is trading at USD 36.88 with a total of 622,231 shares traded.
Over the past week, the price has changed by -2.95%, over one month by -4.40%, over three months by -10.45% and over the past year by +37.69%.
Neither. Based on ValueRay´s Fundamental Analyses, CNO Financial is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 16.76 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CNO is around 37.48 USD . This means that CNO is currently overvalued and has a potential downside of 1.63%.
CNO Financial has received a consensus analysts rating of 2.83. Therefor, it is recommend to hold CNO.
- Strong Buy: 0
- Buy: 1
- Hold: 4
- Sell: 0
- Strong Sell: 1
According to our own proprietary Forecast Model, CNO CNO Financial will be worth about 42.5 in June 2026. The stock is currently trading at 36.88. This means that the stock has a potential upside of +15.13%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 44 | 19.3% |
Analysts Target Price | 44.2 | 19.8% |
ValueRay Target Price | 42.5 | 15.1% |